ahlam1399
09-04-2015, 04:10 AM
UPDATE 1-FDA approves longer-term use of AstraZeneca blood thinner
Sept 3 (Reuters) - AstraZeneca Plc on Thursday said the U.S. Food and Drug Administration approved a new dose of its blood thinner Brilinta intended for longer-term use in patients with a history of heart attack or a condition k**wn as acute coronary syndrome.
http://rc.feedsportal.com/r/238385184121/u/49/f/654213/c/35217/s/498e1253/sc/28/rc/1/rc.img (http://rc.feedsportal.com/r/238385184121/u/49/f/654213/c/35217/s/498e1253/sc/28/rc/1/rc.htm)
http://rc.feedsportal.com/r/238385184121/u/49/f/654213/c/35217/s/498e1253/sc/28/rc/2/rc.img (http://rc.feedsportal.com/r/238385184121/u/49/f/654213/c/35217/s/498e1253/sc/28/rc/2/rc.htm)
http://rc.feedsportal.com/r/238385184121/u/49/f/654213/c/35217/s/498e1253/sc/28/rc/3/rc.img (http://rc.feedsportal.com/r/238385184121/u/49/f/654213/c/35217/s/498e1253/sc/28/rc/3/rc.htm)
http://da.feedsportal.com/r/238385184121/u/49/f/654213/c/35217/s/498e1253/sc/28/a2.img (http://da.feedsportal.com/r/238385184121/u/49/f/654213/c/35217/s/498e1253/sc/28/a2.htm)
http://adchoice.feedsportal.com/r/238385184121/u/49/f/654213/c/35217/s/498e1253/sc/28/ach.img (http://adchoice.feedsportal.com/r/238385184121/u/49/f/654213/c/35217/s/498e1253/sc/28/ach.htm)http://pi.feedsportal.com/r/238385184121/u/49/f/654213/c/35217/s/498e1253/sc/28/a2t.imghttp://pi2.feedsportal.com/r/238385184121/u/49/f/654213/c/35217/s/498e1253/sc/28/a2t2.imghttp://i2.wp.com/reuters.us.feedsportal.com/c/35217/f/654213/s/498e1253/sc/28/mf.gif?resize=1%2C1http://feeds.feedburner.com/~ff/reuters/companyNews?d=yIl2AUoC8zA (http://feeds.reuters.com/~ff/reuters/companyNews?a=tz3nUY4fw34:n3guujAGl_0:yIl2AUoC8zA) http://feeds.feedburner.com/~ff/reuters/companyNews?i=tz3nUY4fw34:n3guujAGl_0:V_sGLiPBpWU (http://feeds.reuters.com/~ff/reuters/companyNews?a=tz3nUY4fw34:n3guujAGl_0:V_sGLiPBpWU) http://feeds.feedburner.com/~ff/reuters/companyNews?i=tz3nUY4fw34:n3guujAGl_0:F7zBnMyn0Lo (http://feeds.reuters.com/~ff/reuters/companyNews?a=tz3nUY4fw34:n3guujAGl_0:F7zBnMyn0Lo)
http://feeds.feedburner.com/~r/reuters/companyNews/~4/tz3nUY4fw34
Sept 3 (Reuters) - AstraZeneca Plc on Thursday said the U.S. Food and Drug Administration approved a new dose of its blood thinner Brilinta intended for longer-term use in patients with a history of heart attack or a condition k**wn as acute coronary syndrome.
http://rc.feedsportal.com/r/238385184121/u/49/f/654213/c/35217/s/498e1253/sc/28/rc/1/rc.img (http://rc.feedsportal.com/r/238385184121/u/49/f/654213/c/35217/s/498e1253/sc/28/rc/1/rc.htm)
http://rc.feedsportal.com/r/238385184121/u/49/f/654213/c/35217/s/498e1253/sc/28/rc/2/rc.img (http://rc.feedsportal.com/r/238385184121/u/49/f/654213/c/35217/s/498e1253/sc/28/rc/2/rc.htm)
http://rc.feedsportal.com/r/238385184121/u/49/f/654213/c/35217/s/498e1253/sc/28/rc/3/rc.img (http://rc.feedsportal.com/r/238385184121/u/49/f/654213/c/35217/s/498e1253/sc/28/rc/3/rc.htm)
http://da.feedsportal.com/r/238385184121/u/49/f/654213/c/35217/s/498e1253/sc/28/a2.img (http://da.feedsportal.com/r/238385184121/u/49/f/654213/c/35217/s/498e1253/sc/28/a2.htm)
http://adchoice.feedsportal.com/r/238385184121/u/49/f/654213/c/35217/s/498e1253/sc/28/ach.img (http://adchoice.feedsportal.com/r/238385184121/u/49/f/654213/c/35217/s/498e1253/sc/28/ach.htm)http://pi.feedsportal.com/r/238385184121/u/49/f/654213/c/35217/s/498e1253/sc/28/a2t.imghttp://pi2.feedsportal.com/r/238385184121/u/49/f/654213/c/35217/s/498e1253/sc/28/a2t2.imghttp://i2.wp.com/reuters.us.feedsportal.com/c/35217/f/654213/s/498e1253/sc/28/mf.gif?resize=1%2C1http://feeds.feedburner.com/~ff/reuters/companyNews?d=yIl2AUoC8zA (http://feeds.reuters.com/~ff/reuters/companyNews?a=tz3nUY4fw34:n3guujAGl_0:yIl2AUoC8zA) http://feeds.feedburner.com/~ff/reuters/companyNews?i=tz3nUY4fw34:n3guujAGl_0:V_sGLiPBpWU (http://feeds.reuters.com/~ff/reuters/companyNews?a=tz3nUY4fw34:n3guujAGl_0:V_sGLiPBpWU) http://feeds.feedburner.com/~ff/reuters/companyNews?i=tz3nUY4fw34:n3guujAGl_0:F7zBnMyn0Lo (http://feeds.reuters.com/~ff/reuters/companyNews?a=tz3nUY4fw34:n3guujAGl_0:F7zBnMyn0Lo)
http://feeds.feedburner.com/~r/reuters/companyNews/~4/tz3nUY4fw34